Apyx Medical Corporation (APYX)
Automate Your Wheel Strategy on APYX
With Tiblio's Option Bot, you can configure your own wheel strategy including APYX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol APYX
- Rev/Share 1.2552
- Book/Share 0.1593
- PB 26.1679
- Debt/Equity 0.7874
- CurrentRatio 4.4442
- ROIC -0.2069
- MktCap 153411488.0
- FreeCF/Share -0.2487
- PFCF -16.1622
- PE -10.5247
- Debt/Assets 0.0803
- DivYield 0
- ROE -1.5377
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | APYX | Citizens JMP | Market Perform | Mkt Outperform | -- | -- | Nov. 14, 2025 |
| Upgrade | APYX | Citizens JMP | Market Perform | Mkt Outperform | -- | $8 | Nov. 12, 2025 |
| Initiation | APYX | BTIG Research | -- | Neutral | -- | -- | Oct. 17, 2024 |
News
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
Published: November 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the pricing of its previously announced underwritten public offering of 2,762,431 shares of its common stock at a public offering price of $3.62 per share of common stock, before deducting underwriting discounts and commissions and offering expenses.
Read More
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Published: November 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Read More
Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript
Published: November 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Apyx Medical Corporation ( APYX ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Charles Goodwin - President, CEO & Director Matthew Hill - CFO, Treasurer & Secretary Conference Call Participants Jeremy Feffer - Lifesci Advisors, LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Alex Fuhrman - Lucid Capital Markets, LLC, Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Apyx Medical Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being …
Read More
Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Charles D. Goodwin - President, CEO & Director Matthew C.
Read More
Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript
Published: March 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Apyx Medical Corporation (NASDAQ:APYX ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Jeremy Feffer - MD, LifeSci Advisors Charlie Goodwin - CEO Matt Hill - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Sam Eiber - BTIG Operator Greetings. Welcome to the Apyx Medical Fourth Quarter and Full Year 2024 Conference Call.
Read More
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Negative
Apyx Medical (APYX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.19 per share a year ago.
Read More
About Apyx Medical Corporation (APYX)
- IPO Date 2019-01-02
- Website https://www.apyxmedical.com
- Industry Medical - Devices
- CEO Charles D. Goodwin II
- Employees 220